Table 2. Rates of Central Nervous System Events in the ASSENT-1 Trial
TNK-tPA
30 mg
TNK-tPA
40mg
TNK-tPA
50mg
Total
Total stroke
26 (1.5%)
22 (1.5%)
0
48 (1.5%)
ICH
16 (0.94%)
9 (0.62%)
0
25 (0.77%)
Ischemic stroke
9 (0.5%)
14 (1%)
0
23 (0.7%)
Cerebral infarction with hemorrhagic conversion
1 (0.1%)
1 (0.1%)
0
2 (0.1%)
Unknown type
1 (0.1%)
1 (0.1%)
0
2 (0.1%)

Total stroke includes hemorrhagic, nonhemorrhagic, and cerebral infarction with hemorrhagic conversion